spiperone has been researched along with Weight Loss in 1 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
Weight Loss: Decrease in existing BODY WEIGHT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pfaffly, J | 1 |
| Michaelides, M | 1 |
| Wang, GJ | 1 |
| Pessin, JE | 1 |
| Volkow, ND | 1 |
| Thanos, PK | 1 |
1 other study available for spiperone and Weight Loss
| Article | Year |
|---|---|
Leptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice.
Topics: Analysis of Variance; Animals; Autoradiography; Caudate Nucleus; Corpus Striatum; Eating; Genotype; | 2010 |